Travere Therapeutics insider Inrig Jula exercised Options covering 32,395 shares at $8.93 each, then sold 44,674 shares across four transactions priced from $62.02 to $65.31. The disclosure gives investors post-transaction holdings of 145,165 shares after the exercise and 100,491 shares after the sales.

Key Highlights

  • Inrig Jula’s post-exercise share position was 145,165.
  • Four sales transactions covered 44,674 shares at prices ranging from $62.02 to $65.31.
  • The option exercise represented about 42.6% of Jula’s prior derivative-securities holding.

Travere Therapeutics, Inc. is a biotechnology company. Inrig Jula exercised options covering 32,395 shares at $8.93 per share, a transaction that left Jula with 145,165 shares. The transaction took place on 15 September 2026 and carried SEC transaction code M.

Four Share Sales Follow Option Exercise

Transaction code M identifies an option exercise. On the same date, Jula sold 44,674 shares in four separate transactions, with prices spanning $62.02 to $65.31 per share.

Holdings Span Shares and Derivative Securities

The derivative-securities position after the exercise was 43,605, while the transaction represented about 42.6% of Jula’s prior derivative-securities holding. The share exercise represented about 22.3% of the resulting shares holding. The sales represented about 30.8% of Jula’s prior shares holding. The share calculations use different reference points, with the exercise tied to the resulting holding and the sales tied to the prior holding.